Clinical Trials Browser

Phase 2 × Neoplasms × ridaforolimus × Clear all

NCT00110188 2015-11-20

Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)

Phase 2 Completed

Neoplasms, Prostatic Neoplasms

NCT00122343 2015-02-19

AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)

Phase 2 Completed

Neoplasms, Endometrial Neoplasms